Barrenjoey says ACCC overplaying Chemist Warehouse’s supply risks
The competition regulator entirely ignored a major wholesaler when it warned that smaller pharmacies may have fewer independent suppliers to choose from should Chemist Warehouse be allowed to merge with Sigma Healthcare in an $8.8 billion reverse takeover, Barrenjoey says.
The investment bank’s brokers said CH2 – Clifford Hallam Healthcare – appeared not to be included in the calculations of the wholesale retail pharmacy supply chain when the Australian Competition and Consumer Commission initially reviewed the mega transaction.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Retail
Fetching latest articles